$TSNDF
TerrAscend Corp.

2023 Q3 Form 10-Q Financial Statement

#000095017023041289 Filed on August 10, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $89.24M $72.12M
YoY Change 33.14% 11.3%
Cost Of Revenue $41.44M $35.90M
YoY Change -2.88% -14.14%
Gross Profit $47.81M $36.23M
YoY Change 96.22% 57.55%
Gross Profit Margin 53.57% 50.23%
Selling, General & Admin $29.30M $30.48M
YoY Change -0.29% -10.31%
% of Gross Profit 61.29% 84.13%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $5.419M $3.395M
YoY Change 80.27% 12.16%
% of Gross Profit 11.34% 9.37%
Operating Expenses $31.96M $32.73M
YoY Change -91.21% -11.54%
Operating Profit $15.84M $3.498M
YoY Change -104.67% -124.98%
Interest Expense -$13.38M -$9.310M
YoY Change 305.39% -124.62%
% of Operating Profit -84.47% -266.15%
Other Income/Expense, Net $120.0K -$206.0K
YoY Change -88.3% -31.56%
Pretax Income $5.104M -$6.407M
YoY Change -101.48% -133.99%
Income Tax $13.54M $6.448M
% Of Pretax Income 265.34%
Net Earnings -$8.671M -$13.48M
YoY Change -97.23% -201.96%
Net Earnings / Revenue -9.72% -18.68%
Basic Earnings Per Share -$0.04 -$0.05
Diluted Earnings Per Share -$0.04 -$0.05
COMMON SHARES
Basic Shares Outstanding 287.0M 274.7M
Diluted Shares Outstanding 287.1M 275.2M

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $27.33M $30.80M
YoY Change -27.79% -41.33%
Cash & Equivalents $25.41M $28.92M
Short-Term Investments $1.917M $1.900M
Other Short-Term Assets $7.480M $12.30M
YoY Change -9.06% 48.91%
Inventory $57.40M $54.02M
Prepaid Expenses
Receivables $15.00M $9.478M
Other Receivables $1.106M $1.100M
Total Short-Term Assets $107.2M $106.6M
YoY Change -5.45% -22.35%
LONG-TERM ASSETS
Property, Plant & Equipment $199.4M $209.0M
YoY Change -18.32% -12.48%
Goodwill $105.6M $99.95M
YoY Change 16.93% -58.46%
Intangibles $274.2M $269.6M
YoY Change 14.0% -23.33%
Long-Term Investments
YoY Change
Other Assets $844.0K $848.0K
YoY Change -85.03% -83.03%
Total Long-Term Assets $627.5M $615.1M
YoY Change 2.51% -29.4%
TOTAL ASSETS
Total Short-Term Assets $107.2M $106.6M
Total Long-Term Assets $627.5M $615.1M
Total Assets $734.7M $721.7M
YoY Change 1.27% -28.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $51.03M $50.80M
YoY Change -17.26% -11.71%
Accrued Expenses $2.363M $1.900M
YoY Change 540.38% 394.79%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $23.84M $24.20M
YoY Change -69.0% -59.83%
Total Short-Term Liabilities $146.4M $133.5M
YoY Change -15.06% -4.92%
LONG-TERM LIABILITIES
Long-Term Debt $189.5M $189.0M
YoY Change 7.02% 1.85%
Other Long-Term Liabilities $18.54M $16.37M
YoY Change 48.36% 30.92%
Total Long-Term Liabilities $303.5M $292.7M
YoY Change 10.64% -9.46%
TOTAL LIABILITIES
Total Short-Term Liabilities $146.4M $133.5M
Total Long-Term Liabilities $303.5M $292.7M
Total Liabilities $449.9M $426.1M
YoY Change 0.72% -8.09%
SHAREHOLDERS EQUITY
Retained Earnings -$662.1M -$653.6M
YoY Change 9.37% 107.41%
Common Stock $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $284.2M $293.6M
YoY Change
Total Liabilities & Shareholders Equity $734.7M $721.7M
YoY Change 1.27% -28.44%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$8.671M -$13.48M
YoY Change -97.23% -201.96%
Depreciation, Depletion And Amortization $5.419M $3.395M
YoY Change 80.27% 12.16%
Cash From Operating Activities $8.932M $690.0K
YoY Change 478.12% -104.28%
INVESTING ACTIVITIES
Capital Expenditures $1.716M $2.260M
YoY Change -114.09% -123.71%
Acquisitions
YoY Change
Other Investing Activities -$6.696M $8.960M
YoY Change 1734.52% -302.67%
Cash From Investing Activities -$8.412M $6.700M
YoY Change -32.93% -148.02%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $28.24M
YoY Change
Cash From Financing Activities -7.403M -4.980M
YoY Change 128.21% -39.91%
NET CHANGE
Cash From Operating Activities 8.932M 690.0K
Cash From Investing Activities -8.412M 6.700M
Cash From Financing Activities -7.403M -4.980M
Net Change In Cash -6.883M 2.410M
YoY Change -51.67% -106.28%
FREE CASH FLOW
Cash From Operating Activities $8.932M $690.0K
Capital Expenditures $1.716M $2.260M
Free Cash Flow $7.216M -$1.570M
YoY Change -47.42% -76.2%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001778129
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
00-0000000
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2022Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2022 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2023Q2 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentNet
CY2022Q4 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentNet
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
021-340690
dei Entity Registrant Name
EntityRegistrantName
TerrAscend Corp.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
A6
dei Entity Address Address Line1
EntityAddressAddressLine1
77 City Centre Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 501 - East Tower
dei Entity Address City Or Town
EntityAddressCityOrTown
Mississauga
dei Entity Address State Or Province
EntityAddressStateOrProvince
ON
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
L5B 1M5
dei City Area Code
CityAreaCode
717
dei Local Phone Number
LocalPhoneNumber
610-4165
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
286961175
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28915000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26158000
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
3106000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
605000
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9478000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
22443000
CY2023Q2 us-gaap Short Term Investments
ShortTermInvestments
1932000
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
3595000
CY2023Q2 us-gaap Inventory Net
InventoryNet
54015000
CY2022Q4 us-gaap Inventory Net
InventoryNet
46335000
CY2022Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
17349000
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8674000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4937000
CY2023Q2 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
509000
CY2022Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
571000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
106629000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
121993000
CY2023Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2500000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
208995000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
215812000
CY2023Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
406000
CY2022Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
837000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
32824000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
29451000
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
269594000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
239704000
CY2023Q2 us-gaap Goodwill
Goodwill
99952000
CY2022Q4 us-gaap Goodwill
Goodwill
90328000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
848000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3462000
CY2023Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
615119000
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
579594000
CY2023Q2 us-gaap Assets
Assets
721748000
CY2022Q4 us-gaap Assets
Assets
701587000
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
50841000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
44286000
CY2023Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3092000
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2935000
CY2023Q2 us-gaap Loans Payable Current
LoansPayableCurrent
23928000
CY2022Q4 us-gaap Loans Payable Current
LoansPayableCurrent
48335000
CY2023Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
4434000
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
5184000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1911000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1857000
CY2023Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
275000
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
521000
CY2023Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
45934000
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
23077000
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1608000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2599000
CY2023Q2 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
1466000
CY2022Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
9111000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
133489000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
137905000
CY2023Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
180400000
CY2022Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
145852000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
35207000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
31545000
CY2023Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
2139000
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
6713000
CY2023Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
5750000
CY2022Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
711000
CY2023Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
6447000
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
35596000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
30700000
CY2023Q2 tsndf Financing Obligations Noncurrent
FinancingObligationsNoncurrent
10754000
CY2022Q4 tsndf Financing Obligations Noncurrent
FinancingObligationsNoncurrent
11198000
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
16367000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
15792000
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
292660000
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
242511000
CY2023Q2 us-gaap Liabilities
Liabilities
426149000
CY2022Q4 us-gaap Liabilities
Liabilities
380416000
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
286807780
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
259624531
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
0
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
0
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
945926000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
934972000
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1330000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2085000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-653623000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-618260000
CY2023Q2 us-gaap Minority Interest
MinorityInterest
1966000
CY2022Q4 us-gaap Minority Interest
MinorityInterest
2374000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
295599000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
321171000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
721748000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
701587000
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
72437000
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
64221000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
142157000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
113281000
CY2023Q2 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
313000
CY2022Q2 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
261000
us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
635000
us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
736000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
72124000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
63960000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
141522000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
112545000
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
35898000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6407000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
21547000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12921000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11540000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6448000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4688000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19112000
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
40009000
us-gaap Cost Of Revenue
CostOfRevenue
71396000
us-gaap Cost Of Revenue
CostOfRevenue
72970000
CY2023Q2 us-gaap Gross Profit
GrossProfit
36226000
CY2022Q2 us-gaap Gross Profit
GrossProfit
23951000
us-gaap Gross Profit
GrossProfit
70126000
us-gaap Gross Profit
GrossProfit
39575000
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
30476000
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
32925000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
58206000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
54349000
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2242000
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2581000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4271000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4756000
CY2023Q2 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
10000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
345000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
32728000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
35506000
us-gaap Operating Expenses
OperatingExpenses
62822000
us-gaap Operating Expenses
OperatingExpenses
59105000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
3498000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-11555000
us-gaap Operating Income Loss
OperatingIncomeLoss
7304000
us-gaap Operating Income Loss
OperatingIncomeLoss
-19530000
CY2022Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
34000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
153000
CY2023Q2 tsndf Gain Loss On Fair Value Of Warrants And Purchase Option Derivative Asset
GainLossOnFairValueOfWarrantsAndPurchaseOptionDerivativeAsset
215000
CY2022Q2 tsndf Gain Loss On Fair Value Of Warrants And Purchase Option Derivative Asset
GainLossOnFairValueOfWarrantsAndPurchaseOptionDerivativeAsset
47345000
tsndf Gain Loss On Fair Value Of Warrants And Purchase Option Derivative Asset
GainLossOnFairValueOfWarrantsAndPurchaseOptionDerivativeAsset
653000
tsndf Gain Loss On Fair Value Of Warrants And Purchase Option Derivative Asset
GainLossOnFairValueOfWarrantsAndPurchaseOptionDerivativeAsset
53058000
CY2023Q2 tsndf Finance And Other Expenses
FinanceAndOtherExpenses
8171000
CY2022Q2 tsndf Finance And Other Expenses
FinanceAndOtherExpenses
13663000
tsndf Finance And Other Expenses
FinanceAndOtherExpenses
18258000
tsndf Finance And Other Expenses
FinanceAndOtherExpenses
20318000
CY2023Q2 tsndf Transaction And Restructuring Costs
TransactionAndRestructuringCosts
389000
CY2022Q2 tsndf Transaction And Restructuring Costs
TransactionAndRestructuringCosts
627000
tsndf Transaction And Restructuring Costs
TransactionAndRestructuringCosts
392000
tsndf Transaction And Restructuring Costs
TransactionAndRestructuringCosts
1242000
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
101000
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
315000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
132000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-41000
CY2023Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
-1661000
CY2022Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
-234000
us-gaap Gain Loss On Investments
GainLossOnInvestments
-2360000
us-gaap Gain Loss On Investments
GainLossOnInvestments
-234000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8431000
CY2023Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-12855000
CY2022Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
16859000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-32033000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
3109000
CY2023Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-621000
CY2022Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-2697000
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-4212000
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-4953000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-13476000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
14162000
us-gaap Net Income Loss
NetIncomeLoss
-36245000
us-gaap Net Income Loss
NetIncomeLoss
-1844000
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-408000
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-280000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-755000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-3887000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-13884000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
13882000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-37000000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-5731000
CY2023Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-14998000
CY2022Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
15914000
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-36362000
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
1813000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
2143000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
945000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
4329000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
1296000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-16027000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
12937000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-41329000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7027000
CY2023Q2 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
2143000
CY2022Q2 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
945000
us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
4329000
us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
1296000
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.05
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.06
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.13
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.01
CY2022Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
-0.01
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
-0.02
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
-0.02
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
275186279
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
252305425
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
271223233
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
231829926
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.05
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.06
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.13
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.01
CY2022Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-0.01
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-0.02
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-0.02
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
275186279
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
257883711
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
271223233
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
231829926
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
299301000
CY2023Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
9524000
CY2023Q2 tsndf Stock Options And Warrants Issued During Period Value Legal Settlement
StockOptionsAndWarrantsIssuedDuringPeriodValueLegalSettlement
201000
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
7507000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1981000
CY2023Q2 tsndf Noncontrolling Interest Increase Decrease From Capital Contributions
NoncontrollingInterestIncreaseDecreaseFromCapitalContributions
-1531000
CY2023Q2 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
7500000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-13476000
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-408000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
295599000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
525239000
CY2022Q2 tsndf Stock Issued During Period Value Stock Options Warrants And Restricted Stock Units Exercised
StockIssuedDuringPeriodValueStockOptionsWarrantsAndRestrictedStockUnitsExercised
1041000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4463000
CY2022Q2 tsndf Noncontrolling Interest Increase Decrease From Capital Contributions
NoncontrollingInterestIncreaseDecreaseFromCapitalContributions
343000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
14162000
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-280000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
544968000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
321171000
tsndf Stock Issued During Period Value Stock Options Warrants And Restricted Stock Units Exercised
StockIssuedDuringPeriodValueStockOptionsWarrantsAndRestrictedStockUnitsExercised
81000
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
10267000
tsndf Stock Options And Warrants Issued During Period Value Legal Settlement
StockOptionsAndWarrantsIssuedDuringPeriodValueLegalSettlement
794000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3694000
tsndf Noncontrolling Interest Increase Decrease From Capital Contributions
NoncontrollingInterestIncreaseDecreaseFromCapitalContributions
-3415000
us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
7500000
us-gaap Net Income Loss
NetIncomeLoss
-36245000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-755000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
295599000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
228954000
tsndf Stock Issued During Period Value Stock Options Warrants And Restricted Stock Units Exercised
StockIssuedDuringPeriodValueStockOptionsWarrantsAndRestrictedStockUnitsExercised
25743000
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
288044000
tsndf Stock Issued During Period Value Liability Settlement
StockIssuedDuringPeriodValueLiabilitySettlement
22000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7819000
us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
564000
tsndf Noncontrolling Interest Increase Decrease From Capital Contributions
NoncontrollingInterestIncreaseDecreaseFromCapitalContributions
-448000
us-gaap Net Income Loss
NetIncomeLoss
-1844000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3886000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
544968000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-32033000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
3109000
us-gaap Inventory Write Down
InventoryWriteDown
1081000
us-gaap Inventory Write Down
InventoryWriteDown
8495000
tsndf Accretion Expenses Net
AccretionExpensesNet
-5673000
tsndf Accretion Expenses Net
AccretionExpensesNet
-1708000
tsndf Depreciation And Amortization Of Intangible Assets
DepreciationAndAmortizationOfIntangibleAssets
9761000
tsndf Depreciation And Amortization Of Intangible Assets
DepreciationAndAmortizationOfIntangibleAssets
11253000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
932000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1074000
us-gaap Share Based Compensation
ShareBasedCompensation
3694000
us-gaap Share Based Compensation
ShareBasedCompensation
7819000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
815000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-787000
tsndf Gain Lss On Warrants And Derivative
GainLssOnWarrantsAndDerivative
653000
tsndf Gain Lss On Warrants And Derivative
GainLssOnWarrantsAndDerivative
53058000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-345000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
153000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-929000
tsndf Release Of Indemnification Asset
ReleaseOfIndemnificationAsset
3973000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
132000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-41000
tsndf Unrealized And Realized Gain Loss On Investments And Derivatives
UnrealizedAndRealizedGainLossOnInvestmentsAndDerivatives
-2410000
tsndf Unrealized And Realized Gain Loss On Investments And Derivatives
UnrealizedAndRealizedGainLossOnInvestmentsAndDerivatives
-234000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-295000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
445000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7851000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-208000
tsndf Increase Decrease In Prepaid Expenses And Other Current Assets
IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets
319000
tsndf Increase Decrease In Prepaid Expenses And Other Current Assets
IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets
-1434000
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
-431000
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
-206000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-714000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-461000
tsndf Increase Decrease In Accounts Payable And Accrued Liabilities And Other Payables
IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesAndOtherPayables
4089000
tsndf Increase Decrease In Accounts Payable And Accrued Liabilities And Other Payables
IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesAndOtherPayables
-7840000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-337000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-614000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1085000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-10353000
tsndf Increase Decrease In Contingent Consideration Payable
IncreaseDecreaseInContingentConsiderationPayable
-410000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
22127000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
5000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
157000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
766000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
12284000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-31639000
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-3164000
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-3337000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
9120000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-34976000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4504000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12500000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
262000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1330000
us-gaap Proceeds From Collection Of Lease Receivables
ProceedsFromCollectionOfLeaseReceivables
104000
us-gaap Proceeds From Collection Of Lease Receivables
ProceedsFromCollectionOfLeaseReceivables
392000
tsndf Proceeds From Receipt Of Convertible Debenture Payment
ProceedsFromReceiptOfConvertibleDebenturePayment
738000
tsndf Deposits For Property And Equipment
DepositsForPropertyAndEquipment
10036000
tsndf Deposits For Business Acquisition
DepositsForBusinessAcquisition
852000
tsndf Payment For Land Contracts
PaymentForLandContracts
769000
tsndf Payment For Land Contracts
PaymentForLandContracts
429000
tsndf Cash Portion Of Consideration Paid In Acquisitions Net Of Cash Acquired
CashPortionOfConsiderationPaidInAcquisitionsNetOfCashAcquired
14469000
tsndf Cash Portion Of Consideration Paid In Acquisitions Net Of Cash Acquired
CashPortionOfConsiderationPaidInAcquisitionsNetOfCashAcquired
-24716000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-19162000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-39000
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
14285000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4877000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-39000
tsndf Transfer Of Employee Retention Credit
TransferOfEmployeeRetentionCredit
12677000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
23872000
tsndf Proceeds From Options And Warrants Exercised
ProceedsFromOptionsAndWarrantsExercised
81000
tsndf Proceeds From Options And Warrants Exercised
ProceedsFromOptionsAndWarrantsExercised
24158000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
40359000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
4968000
tsndf Payment Loan Amendment Fee And Prepayment Premium
PaymentLoanAmendmentFeeAndPrepaymentPremium
1178000
tsndf Payment Loan Amendment Fee And Prepayment Premium
PaymentLoanAmendmentFeeAndPrepaymentPremium
1200000
us-gaap Payments Of Distributions To Affiliates
PaymentsOfDistributionsToAffiliates
3415000
us-gaap Payments Of Distributions To Affiliates
PaymentsOfDistributionsToAffiliates
1436000
tsndf Payments Of Capital Distribution To Noncontrolling Interest
PaymentsOfCapitalDistributionToNoncontrollingInterest
448000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
6630000
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
19218000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
941000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
460000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
9955000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
9016000
us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
-5539000
us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
-235000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4416000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8781000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
8659000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-26234000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-901000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-4377000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
26763000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
79642000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
34521000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
49031000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-4582000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
9213000
us-gaap Interest Paid Net
InterestPaidNet
9259000
us-gaap Interest Paid Net
InterestPaidNet
14641000
tsndf Payments For Lease Termination Fee
PaymentsForLeaseTerminationFee
3300000
tsndf Business Combination Consideration Transferred Equity Issued And Liabilities Incurred
BusinessCombinationConsiderationTransferredEquityIssuedAndLiabilitiesIncurred
10267000
tsndf Business Combination Consideration Transferred Equity Issued And Liabilities Incurred
BusinessCombinationConsiderationTransferredEquityIssuedAndLiabilitiesIncurred
294800000
tsndf Stock Issued During Period Value For Legal And Liability Settlement
StockIssuedDuringPeriodValueForLegalAndLiabilitySettlement
794000
tsndf Stock Issued During Period Value For Legal And Liability Settlement
StockIssuedDuringPeriodValueForLegalAndLiabilitySettlement
22000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
529000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
9776000
us-gaap Nature Of Operations
NatureOfOperations
<p id="notes" style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Na</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ture of operations</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TerrAscend Corp. (“TerrAscend” or the “Company”) was incorporated under the Ontario Business Corporations Act on </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 7, 2017</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. TerrAscend provides cannabis products, brands, and services to the United States (“U.S.”) and Canadian cannabinoid markets where cannabis production or consumption has been legalized for therapeutic or adult use. TerrAscend operates a number of synergistic businesses, including Gage Growth ("Gage"), a cultivator, processor and retailer in Michigan; KISA Enterprises MI, LLC and KISA Holdings LLC (collectively "Pinnacle"); The Apothecarium (“The Apothecarium”), a cannabis dispensary with several retail locations in California, Pennsylvania and New Jersey; TerrAscend NJ, LLC ("TerrAscend NJ"), a cultivator, processor and retailer with operations in New Jersey; Ilera Healthcare (“Ilera”), Pennsylvania’s medical cannabis cultivator, processor and dispenser; vertically integrated operations in Maryland which include HMS Health, LLC and HMS Processing, LLC (collectively “HMS”), a cannabis cultivator and process</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">or, Allegany Medical Marijuana Dispensary ("AMMD"), Peninsula Alternative Health ("Peninsula"), Blue Ridge Wellness ("Blue Ridge"), and Herbiculture Inc. ("Herbiculture"); Valhalla Confections, a cannabis-infused edibles brand; and State Flower, a California-based cannabis producer operating a licensed cultivation facility in San Francisco. Notwithstanding various states in the U.S. which have implemented medical marijuana laws, or which have otherwise legalized the use of cannabis, the use of cannabis remains illegal under U.S. federal law for any purpose, by way of the Controlled Substances Act of 1970.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Effective July 4, 2023, the Company commenced trading of its common shares on the Toronto Stock Exchange ("TSX"), under the ticker symbol "TSND". Previously from May 3, 2017 to June 30, 2023, common shares of the Company were traded on the Canadian Securities Exchange under ticker symbol "TER". The common shares of the Company began trading on OTCQX on October 22, 2018 under the ticker symbol "TRSSF" and changed its ticker symbol to "TSNDF" effective July 6, 2023. The Company’s registered office is loc</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ated at 77 City Centre Drive, Suite 501, Mississauga, Ontario, L5B 1M5.</span></p>
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2017-03-07
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-653623000
CY2023Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-12855000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-32033000
CY2023Q2 tsndf Trade Receivables Gross
TradeReceivablesGross
19213000
CY2022Q4 tsndf Trade Receivables Gross
TradeReceivablesGross
14786000
CY2023Q2 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
120000
CY2022Q4 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
277000
CY2023Q2 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
994000
CY2022Q4 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
17936000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
10849000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
10556000
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9478000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
22443000
CY2022 us-gaap Payments To Employees
PaymentsToEmployees
14903000
CY2023Q1 us-gaap Proceeds From Sale And Collection Of Receivables
ProceedsFromSaleAndCollectionOfReceivables
12667000
CY2022Q4 tsndf Factoring Interests
FactoringInterests
14903000
tsndf Employee Retension Credits Transfer Fee As Percentage Of Claim
EmployeeRetensionCreditsTransferFeeAsPercentageOfClaim
0.15
tsndf Percentage Of Repay Of Funds Received Plus Interest Accrued
PercentageOfRepayOfFundsReceivedPlusInterestAccrued
0.10
tsndf Proceeds From Employee Retention Credit Financing Agreement
ProceedsFromEmployeeRetentionCreditFinancingAgreement
10059000
CY2023Q2 tsndf Trade Receivables Gross
TradeReceivablesGross
19213000
CY2022Q4 tsndf Trade Receivables Gross
TradeReceivablesGross
14786000
CY2023Q2 tsndf Provisions For Sales Returns And Expected Credit Losses
ProvisionsForSalesReturnsAndExpectedCreditLosses
10849000
CY2022Q4 tsndf Provisions For Sales Returns And Expected Credit Losses
ProvisionsForSalesReturnsAndExpectedCreditLosses
10556000
CY2023Q2 tsndf Trade Receivables Net
TradeReceivablesNet
8364000
CY2022Q4 tsndf Trade Receivables Net
TradeReceivablesNet
4230000
CY2023Q2 tsndf Trade Receivable Current
TradeReceivableCurrent
7393000
CY2022Q4 tsndf Trade Receivable Current
TradeReceivableCurrent
4045000
CY2023Q2 tsndf Trade Receivable3190 Days
TradeReceivable3190Days
1108000
CY2022Q4 tsndf Trade Receivable3190 Days
TradeReceivable3190Days
614000
CY2023Q2 tsndf Trade Receivable Over90 Days
TradeReceivableOver90Days
10712000
CY2022Q4 tsndf Trade Receivable Over90 Days
TradeReceivableOver90Days
10127000
CY2023Q2 tsndf Provisions For Sales Returns And Expected Credit Losses
ProvisionsForSalesReturnsAndExpectedCreditLosses
10849000
CY2022Q4 tsndf Provisions For Sales Returns And Expected Credit Losses
ProvisionsForSalesReturnsAndExpectedCreditLosses
10556000
CY2023Q2 tsndf Trade Receivables Net
TradeReceivablesNet
8364000
CY2022Q4 tsndf Trade Receivables Net
TradeReceivablesNet
4230000
CY2023Q2 tsndf Number Of Customers Agreed To Payment Plan Over Ninety Days
NumberOfCustomersAgreedToPaymentPlanOverNinetyDays
1
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
5184000
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
750000
CY2023Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
4434000
CY2023Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
4434000
CY2023Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
1406000
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1181000
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
20691000
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
15280000
CY2023Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
26891000
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
26406000
CY2023Q2 tsndf Inventory Accessories Supplies And Consumables
InventoryAccessoriesSuppliesAndConsumables
5027000
CY2022Q4 tsndf Inventory Accessories Supplies And Consumables
InventoryAccessoriesSuppliesAndConsumables
3468000
CY2023Q2 us-gaap Inventory Net
InventoryNet
54015000
CY2022Q4 us-gaap Inventory Net
InventoryNet
46335000
CY2023Q2 tsndf Facility Held For Sale
FacilityHeldForSale
67300
CY2023Q2 tsndf Facility Sold
FacilitySold
19700000
CY2023Q2 tsndf Facility Sold
FacilitySold
14285000
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
236844000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
235496000
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
27849000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
19684000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
208995000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
215812000
tsndf Property And Equipment Capitalized Borrowing Costs
PropertyAndEquipmentCapitalizedBorrowingCosts
0
CY2022 tsndf Property And Equipment Capitalized Borrowing Costs
PropertyAndEquipmentCapitalizedBorrowingCosts
0
CY2023Q2 us-gaap Depreciation
Depreciation
3395000
us-gaap Depreciation
Depreciation
6652000
CY2022Q2 us-gaap Depreciation
Depreciation
3027000
us-gaap Depreciation
Depreciation
4684000
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
211094000
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
24257000
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
186837000
CY2023Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
82757000
CY2023Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
82757000
CY2023Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
293851000
CY2023Q2 tsndf Intangible Assets Excluding Goodwill Accumulated Amortization
IntangibleAssetsExcludingGoodwillAccumulatedAmortization
24257000
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
269594000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
181522000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
24575000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
156947000
CY2022Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
82757000
CY2022Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
82757000
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
264279000
CY2022Q4 tsndf Intangible Assets Excluding Goodwill Accumulated Amortization
IntangibleAssetsExcludingGoodwillAccumulatedAmortization
24575000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
239704000
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1595000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3109000
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3871000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6333000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
4501000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
8662000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
8396000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
8381000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
8301000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2022Q4 us-gaap Goodwill
Goodwill
90328000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
9004000
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
620000
CY2023Q2 us-gaap Goodwill
Goodwill
99952000
CY2022Q4 us-gaap Loans Payable
LoansPayable
194187000
tsndf Loan Principal Net Of Transaction Costs
LoanPrincipalNetOfTransactionCosts
47857000
tsndf Loan Amendment Fee Or Prepayment Penalty
LoanAmendmentFeeOrPrepaymentPenalty
2328000
us-gaap Interest Expense Long Term Debt Increase Decrease
InterestExpenseLongTermDebtIncreaseDecrease
14230000
us-gaap Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
49618000
CY2023Q2 us-gaap Loans Payable
LoansPayable
204328000
CY2023Q2 us-gaap Loans Payable Current
LoansPayableCurrent
23928000
CY2023Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
180400000
CY2023Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
6803000
us-gaap Interest Expense Debt
InterestExpenseDebt
9259000
CY2022Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
6370000
us-gaap Interest Expense Debt
InterestExpenseDebt
14406000
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
13845000
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
137216000
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
8466000
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
3649000
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
43219000
CY2023Q2 tsndf Long Term Debt Maturities Repayments Of Principal After Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour
2264000
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
208659000
tsndf Number Of Finance Lease
NumberOfFinanceLease
2
CY2022 tsndf Number Of Finance Lease
NumberOfFinanceLease
3
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
32824000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
29451000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1911000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1857000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
35207000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
31545000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
37118000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
33402000
CY2023Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
2374000
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
6673000
CY2023Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
275000
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
521000
CY2023Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
2139000
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
6713000
CY2023Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
2414000
CY2022Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
7234000
CY2023Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
1254000
us-gaap Operating Lease Expense
OperatingLeaseExpense
2451000
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
1173000
us-gaap Operating Lease Expense
OperatingLeaseExpense
2355000
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P12Y10M24D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P12Y9M18D
CY2023Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P0Y8M12D
CY2022Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P6Y9M18D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1104
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1069
CY2023Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0947
CY2022Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0989
us-gaap Operating Lease Payments
OperatingLeasePayments
2451000
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
5053000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3764000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3097000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
254000
CY2022 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
220000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
6913000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
4326000
CY2023Q2 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
96000
CY2023Q2 tsndf Operating And Finance Lease Liability Payments Remainder Of Fiscal Year
OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
4422000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
6054000
CY2023Q2 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
2130000
CY2023Q2 tsndf Operating And Finance Lease Liability Payments Due Next Twelve Months
OperatingAndFinanceLeaseLiabilityPaymentsDueNextTwelveMonths
8184000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
6045000
CY2023Q2 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
132000
CY2023Q2 tsndf Operating And Finance Lease Liability Payments Due Year Two
OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo
6177000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
5570000
CY2023Q2 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
134000
CY2023Q2 tsndf Operating And Finance Lease Liability Payments Due Year Three
OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree
5704000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
5080000
CY2023Q2 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
136000
CY2023Q2 tsndf Operating And Finance Lease Liability Payments Due Year Four
OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour
5216000
CY2023Q2 tsndf Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
48419000
CY2023Q2 tsndf Finance Lease Liability Payments Due After Year Four
FinanceLeaseLiabilityPaymentsDueAfterYearFour
81000
CY2023Q2 tsndf Operating And Finance Lease Liability Payments Due After Year Four
OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour
48500000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
75494000
CY2023Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
2709000
CY2023Q2 tsndf Operating And Finance Lease Liability Payments Due
OperatingAndFinanceLeaseLiabilityPaymentsDue
78203000
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
38376000
CY2023Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
295000
CY2023Q2 tsndf Operating And Finance Lease Liability Undiscounted Excess Amount
OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount
38671000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
37118000
CY2023Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
2414000
CY2023Q2 tsndf Operating And Finance Lease Liability
OperatingAndFinanceLeaseLiability
39532000
CY2023Q2 us-gaap Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year
LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
313000
CY2023Q2 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
551000
CY2023Q2 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
445000
CY2023Q2 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
262000
CY2023Q2 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
1571000
CY2023Q2 tsndf Financing Obligations Due In Remainder Of Fiscal Year
FinancingObligationsDueInRemainderOfFiscalYear
974000
CY2023Q2 tsndf Financing Obligations Due In Next Twelve Months
FinancingObligationsDueInNextTwelveMonths
1940000
CY2023Q2 tsndf Financing Obligations Due In Second Year
FinancingObligationsDueInSecondYear
1986000
CY2023Q2 tsndf Financing Obligations Due In Third Year
FinancingObligationsDueInThirdYear
2032000
CY2023Q2 tsndf Financing Obligations Due In Fourth Year
FinancingObligationsDueInFourthYear
2079000
CY2023Q2 tsndf Financing Obligations Due After Fourth Year
FinancingObligationsDueAfterFourthYear
5680000
CY2023Q2 tsndf Financing Obligations Due
FinancingObligationsDue
14691000
CY2023Q2 tsndf Financing Obligations Undiscounted Excess Amount
FinancingObligationsUndiscountedExcessAmount
3077000
CY2023Q2 tsndf Financing Obligations
FinancingObligations
11614000
tsndf Conversion Option Issued In Private Placement
ConversionOptionIssuedInPrivatePlacement
3533000
CY2023Q2 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
6572000
tsndf Warrants And Rights Description
WarrantsAndRightsDescription
Each unit is comprised of one common share of the Company and one-half warrant to purchase one common share. Each warrant entitles the holder to acquire one common share at a price of $1.95 per common share for a period of 24 months following the date of issuance.
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1981000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4463000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3694000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7819000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
20111246
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y10M9D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.63
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
320000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
706627
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.75
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
405134
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.19
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1386353
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.38
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
1507019
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
4.2
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
17519367
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y8M23D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.65
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1047000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
11633165
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y11M23D
CY2023Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
3.58
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
202000
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
5886199
tsndf Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageRemainingContractualTerm
P8Y2M19D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
3.81
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
845000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
79000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
551000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
140000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.8004
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.8016
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.7755
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.7789
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0285
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0321
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0163
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0351
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y3D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
tsndf Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeitures Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeituresRate
0.2611
CY2022 tsndf Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeitures Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeituresRate
0.2611
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
5563000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
9140000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
415640
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
13050
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
1785092
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
113640
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
78634
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
2008458
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
14564
CY2022Q4 us-gaap Minority Interest
MinorityInterest
2374000
CY2021Q4 us-gaap Minority Interest
MinorityInterest
5367000
tsndf Minority Interest Capital And Distributions Contributions
MinorityInterestCapitalAndDistributionsContributions
-3415000
CY2022 tsndf Minority Interest Capital And Distributions Contributions
MinorityInterestCapitalAndDistributionsContributions
-7550000
tsndf Transfer Of Minority Interest
TransferOfMinorityInterest
-1323000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
4330000
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
4557000
CY2023Q2 us-gaap Minority Interest
MinorityInterest
1966000
CY2022Q4 us-gaap Minority Interest
MinorityInterest
2374000
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-1.01
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-1.48
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.25
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
1.28
CY2023Q2 tsndf Office And General Expense
OfficeAndGeneralExpense
3801000
CY2022Q2 tsndf Office And General Expense
OfficeAndGeneralExpense
5821000
tsndf Office And General Expense
OfficeAndGeneralExpense
7805000
tsndf Office And General Expense
OfficeAndGeneralExpense
9101000
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
5103000
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
3373000
tsndf Loan Interest Accretion
LoanInterestAccretion
15840000
CY2022Q2 tsndf Loan Interest Accretion
LoanInterestAccretion
8515000
us-gaap Professional Fees
ProfessionalFees
8476000
us-gaap Professional Fees
ProfessionalFees
6093000
CY2023Q2 tsndf Operating And Finance Lease Expense
OperatingAndFinanceLeaseExpense
1294000
CY2022Q2 tsndf Operating And Finance Lease Expense
OperatingAndFinanceLeaseExpense
1099000
tsndf Operating And Finance Lease Expense
OperatingAndFinanceLeaseExpense
2538000
tsndf Operating And Finance Lease Expense
OperatingAndFinanceLeaseExpense
2345000
CY2023Q2 tsndf Facility And Maintenance Expense
FacilityAndMaintenanceExpense
1364000
CY2022Q2 tsndf Facility And Maintenance Expense
FacilityAndMaintenanceExpense
813000
tsndf Facility And Maintenance Expense
FacilityAndMaintenanceExpense
2608000
tsndf Facility And Maintenance Expense
FacilityAndMaintenanceExpense
1450000
CY2023Q2 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
14334000
CY2022Q2 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
13147000
us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
27830000
us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
21945000
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1981000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4463000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3694000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7819000
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2599000
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4209000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5255000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5596000
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
30476000
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
32925000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
58206000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
54349000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
72124000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
63960000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
141522000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
112545000
tsndf Number Of Major Customers
NumberOfMajorCustomers
0
tsndf Number Of Major Customers
NumberOfMajorCustomers
0
tsndf Sales Returns
SalesReturns
1040000
CY2023Q2 tsndf Loan Interest Accretion
LoanInterestAccretion
7965000
tsndf Loan Interest Accretion
LoanInterestAccretion
15412000
CY2022Q2 tsndf Indemnification Asset Release
IndemnificationAssetRelease
3998000
tsndf Indemnification Asset Release
IndemnificationAssetRelease
3973000
tsndf Employee Retention Credits Transfer With Recourse
EmployeeRetentionCreditsTransferWithRecourse
2235000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-206000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1150000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-183000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-933000
CY2023Q2 tsndf Finance And Other Expenses
FinanceAndOtherExpenses
8171000
CY2022Q2 tsndf Finance And Other Expenses
FinanceAndOtherExpenses
13663000
tsndf Finance And Other Expenses
FinanceAndOtherExpenses
18258000
tsndf Finance And Other Expenses
FinanceAndOtherExpenses
20318000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023Q2 us-gaap Noncurrent Assets
NoncurrentAssets
615119000
CY2022Q4 us-gaap Noncurrent Assets
NoncurrentAssets
579594000
CY2023Q2 tsndf Fair Value Assets Transfer Between Levels Amount
FairValueAssetsTransferBetweenLevelsAmount
0
tsndf Fair Value Assets Transfer Between Levels Amount
FairValueAssetsTransferBetweenLevelsAmount
0
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
711000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
703000
tsndf Conversion Option Issued In Private Placement
ConversionOptionIssuedInPrivatePlacement
3533000
tsndf Detachable Warrants Issued In Private Placement
DetachableWarrantsIssuedInPrivatePlacement
2216000
tsndf Effects Of Movements In Foreign Exchange
EffectsOfMovementsInForeignExchange
-7000
CY2023Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
5750000

Files In Submission

Name View Source Status
0000950170-23-041289-index-headers.html Edgar Link pending
0000950170-23-041289-index.html Edgar Link pending
0000950170-23-041289.txt Edgar Link pending
0000950170-23-041289-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tsndf-20230630.htm Edgar Link pending
tsndf-20230630.xsd Edgar Link pending
tsndf-ex10_10.htm Edgar Link pending
tsndf-ex10_11.htm Edgar Link pending
tsndf-ex10_7.htm Edgar Link pending
tsndf-ex10_8.htm Edgar Link pending
tsndf-ex10_9.htm Edgar Link pending
tsndf-ex31_1.htm Edgar Link pending
tsndf-ex31_2.htm Edgar Link pending
tsndf-ex32_1.htm Edgar Link pending
tsndf-ex32_2.htm Edgar Link pending
tsndf-20230630_def.xml Edgar Link unprocessable
tsndf-20230630_lab.xml Edgar Link unprocessable
tsndf-20230630_pre.xml Edgar Link unprocessable
tsndf-20230630_htm.xml Edgar Link completed
tsndf-20230630_cal.xml Edgar Link unprocessable